Full name
OPTIPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.99.Z - Retail trade
52.10.B - Warehousing and storage of other goods
70.21.Z - Head office activities and management consultancy
70.22.Z - Head office activities and management consultancy
82.99.Z - Other business support activities, not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0 | -0 | 22,1 |
EBITDA | 3051,1 | |||
Short time liabilities | -91,7 | |||
Income tax | 0 | 0 | 0 | 0 |
Equity capital | 0,3 | 0,3 | 0,3 | -3 |
Operating profit (EBIT) | 2603,1 | |||
Assets | 0,4 | 0,4 | 0,4 | 10,6 |
Net profit (loss) | -0 | -0 | -0 | 22,1 |
Cash | 885,3 | |||
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,1 | 48,6 |
Net income from sale | -88,8 | |||
Working assets | 0,2 | 0 | 0 | 40,9 |
Basic operational activity income | 0 | 0 | 0 | 0 |
Depreciation | -58,3 | |||
% | % | % | p.p. | |
Profitability of capital | -10,2 | -3,8 | -3,1 | 0,7 |
Equity capital to total assets | 77 | 73,7 | 64,6 | -9,1 |
Gross profit margin | 391,8 | |||
EBITDA Margin | 396,5 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | -34 | |||
Current financial liquidity indicator | 2,3 | |||
Net dept to EBITDA | 16,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane